Mylan has agreed to buy certain women’s health-care businesses from India’s Famy Care Ltd. for $750 million in cash, in a move that will position Mylan as a leading provider of contraceptives in emerging markets.
from WSJ.com: US Business http://ift.tt/1z5IVas
via IFTTT
from WSJ.com: US Business http://ift.tt/1z5IVas
via IFTTT
No comments:
Post a Comment